<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Syndromol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Syndromol</journal-id>
<journal-id journal-id-type="publisher-id">MSY</journal-id>
<journal-title-group>
<journal-title>Molecular Syndromology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1661-8769</issn>
<issn pub-type="epub">1661-8777</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30800045</article-id>
<article-id pub-id-type="pmc">6381894</article-id>
<article-id pub-id-type="doi">10.1159/000492706</article-id>
<article-id pub-id-type="publisher-id">msy-0009-0295</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Novel Insights from Clinical Practice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Transcriptome Sequencing Confirms Activation of a Cryptic Splice Site in Suspected <italic>SYNGAP1</italic>-Related Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Brimble</surname>
<given-names>Elise</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee-Messer</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagy</surname>
<given-names>Peter L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Propst</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruzhnikov</surname>
<given-names>Maura R.Z.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Department of Neurology and Neurological Sciences, Stanford, CA</aff>
<aff id="aff2"><sup>b</sup>Division of Medical Genetics, Department of Pediatrics, Stanford Medicine, Stanford, CA</aff>
<aff id="aff3"><sup>c</sup>MNG Laboratories, Atlanta, GA</aff>
<aff id="aff4"><sup>d</sup>Division of Clinical Genetics, Virginia Commonwealth University Health System, Richmond, VA, USA</aff>
<author-notes>
<corresp id="cor1">*Elise Brimble, Department of Neurology and Neurological Sciences, Stanford Medicine, 291 Campus Drive, Li Ka Shing Building, Stanford, CA 94305 (USA), E-Mail <email>ebrimble@stanfordchildrens.org</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>7</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>9</volume>
<issue>6</issue>
<fpage>295</fpage>
<lpage>299</lpage>
<history>
<date date-type="accepted">
<day>31</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="subscription-year">
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p><italic>SYNGAP1</italic> encodes a brain-specific Ras GTPase activating protein (GAP) that regulates synaptic strength in glutamatergic neurons. Pathogenic variants in this gene are associated with a neurodevelopmental disorder characterized by intellectual and developmental disabilities, generalized epilepsy, hypotonia, and autism spectrum disorders. We describe a young male with suspected <italic>SYNGAP1</italic>-related disorder given clinical overlap and identification of an intronic variant of uncertain significance; clinical transcriptome analysis demonstrated activation of a cryptic acceptor splice site resulting in frameshift and introduction of a stop codon. This report highlights the utility of functional studies newly available to clinical practice in confirming a suspected genetic diagnosis, which can directly impact medical management and preclude the need for additional diagnostic testing.</p>
</abstract>
<kwd-group>
<title>Key Words</title>
<kwd>Intronic variation</kwd>
<kwd>RNA sequencing</kwd>
<kwd>
<italic>SYNGAP1</italic>
</kwd>
<kwd>Transcriptome</kwd>
<kwd>Variant interpretation</kwd>
</kwd-group>
<counts>
<table-count count="1"></table-count>
<ref-count count="22"></ref-count>
<page-count count="5"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>